Anurag Singh

Radiation Oncology
2022 Buffalo Spree Top Docs badge

Dr. Singh is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.

Top Doctors 2022

Specializing In:

Breast cancer Head and neck cancer Lung cancer Prostate cancer

Special Interests:

SBRT (Stereotactic Body Radiation Therapy) Novel agents to improve radiation therapy Novel agents to protect against side effects of radiation therapy Development and implementation of imaging to improve radiation targeting Methods to improve quality of life following radiation therapy Impact of nutrition on patient outcomes

About Anurag Singh


Roswell Park Comprehensive Cancer Center

  • Professor of Oncology
  • Director of Radiation Research, Department of Radiation Medicine
  • Co-Leader, Cell Stress and Biophysical Therapies Program
  • Associate Dean of Graduate Medical Education, Research

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo

  • Professor of Medicine


Education and Training:

  • MD - Washington University School of Medicine, St. Louis, MO
  • BS - Yale University


  • Mallinckrodt Institute of Radiology, St. Louis, MO

Board Certification:

  • Radiation Oncology, American Board of Radiology

Professional Experience:

  • 09/2012-Present - Professor of Medicine, University at Buffalo
  • 07/2012-Present - Professor of Oncology, Director of Radiation Research, Roswell Park Cancer Institute
  • 07/2007–07/2012 - Associate Professor, Director of Radiation Medicine Residency Program, Director of Radiation Research, Roswell Park Cancer Institute, University at Buffalo
  • 07/2004-06/2007 - Attending Physician, Head of Molecular Imaging Section, Radiation Oncology Branch, National Cancer Institute

Honors & Awards:

  • 2013-20 - Top Doctors in Western New York (Castle Connolly)
  • 2020 - Educator of the Year (2019-2020), Association of Residents In Radiation Oncology (ARRO)
  • 2017 - ASTRO Basic/Translational Science Abstract Award, Sr. Investigator in the Clinical category for, “A Pilot Study of Stereotactic Body Radiation Therapy Combined With Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.”
  • 2016 - Walter T. Murphy Educator of the Year Award given by the Radiation Medicine residents for excellence in clinical education
  • 2016 - Commendation from ACGME Residency Progam Review: No citations & excellent compliance
  • 2015 - Commendation from ACGME Residency Progam Review: No citations & excellent compliance
  • 2011 Outstanding Accreditation Award from University at Buffalo, No citations and Commendable Practice ACGME Residency Program Review
  • 2010 - Educator of the Year (2009-2010), Association of Residents In Radiation Oncology (ARRO)
  • 2006 - CaPSure Mentor (for Nicole SImone)
  • 1995 - MENSA Research and Education Scholarship
  • 1995 - Magna Cum Laude Graduate, Yale University
  • 1994 - MENSA Research and Education Scholarship
  • 1994 - Xerox Technical Merit Scholarship


Research Overview:

Dr. Singh's research seeks to improve patient survival and/or quality of life. Partnerships with basic scientists, epidemiologists, statisticians, physicians from other specialties, and hosts of additional experts develop novel, cutting edge care strategies which are then tested in clinical trials. Projects range from the ways radiation impacts the immune system immune system to new agents and approaches to limit the side effects of chemotherapy and radiation.

Clinical Trials

Featured on Cancer Talk


Full Publications list on PubMed

Representative Publications:

1. Hermann GM, Iovoli AJ, Platek AJ, Wang C, Miller A, Attwood K, Bourgeois DJ, Singh AK. A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer. Cancer. 2020 Apr 1;126(7):1480-1491. doi: 10.1002/cncr.32676. Epub 2019 Dec 23. PubMed PMID: 31869451; PubMed Central PMCID: PMC7069789.

2. Singh AK, Gomez-Suescun JA, Stephans KL, Bogart JA, Hermann GM, Tian L, Groman A, Videtic GM. One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):752-759. doi: 10.1016/j.ijrobp.2019.08.019. Epub 2019 Aug 22. PubMed PMID: 31445956; PubMed Central PMCID: PMC7043929.

3. Singh AK, Winslow TB*, Kermany MH, Goritz V, Heit L, Miller A, Hoffend NC, Stein LC, Kumaraswamy LK, Warren GW, Bshara W, Odunsi K, Matsuzaki J, Abrams SI, Schwaab T, Muhitch JB. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2017 Sep 1;23(17):5055-5065. doi: 10.1158/1078-0432.CCR-16-2946. Epub 2017 Jun 19. PubMed PMID: 28630212; PubMed Central PMCID: PMC5581708.

4. Chow J, Hoffend NC, Abrams SI, Schwaab T, Singh AK, Muhitch JB. Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients. Proc Natl Acad Sci U S A. 2020 Sep 8;. doi: 10.1073/pnas.2001933117. [Epub ahead of print] PubMed PMID: 32900949.

5. Chen M, Qiao G, Hylander BL, Mohammadpour H, Wang XY, Subjeck JR, Singh AK, Repasky EA. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat Commun. 2020 Apr 14;11(1):1821. doi: 10.1038/s41467-020-15676-0. PubMed PMID: 32286326; PubMed Central PMCID: PMC7156731.